Samir A. Shah

Samir A. Shah

Auto-generated profile, based on publicly available information

Samir A. Shah

Alpert Medical School of Brown University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
MMMouhand Mohamed
Mouhand Mohamed
DMDaniel Marino
Daniel Marino
KEKhaled Elfert
Khaled Elfert
ABAzizullah Beran
Azizullah Beran
TNTarek Nayfeh
Tarek Nayfeh
SSSamir A. Shah
Samir A. Shah
INTRODUCTION: Whether dye spray chromoendoscopy (DCE) adds value in surveillance colonoscopy with high-definition (HD) scopes remains controversial. This updated meta-analysis compares dysplasia detection using DCE and high-definition white light endoscopy (HD-WLE) in patients with inflammatory bowel disease (IBD) undergoing surveillance colonoscopy. METHODS: A comprehensive search was performed for randomized controlled trials (RCT) comparing HD-WLE and DCE in patients with IBD. The primary outcome was to compare the proportion of patients with at least 1 dysplastic lesion detected by DCE vs HD-WLE. Odds ratios (OR) and 95% confidence intervals (CI) were pooled using the random-effects model, with I 2 > 60% indicating substantial heterogeneity. The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to assess the certainty of evidence (CoE). RESULTS: Six RCT involving 978 patients were analyzed (DCE = 479 vs HD-WLE = 499 patients). DCE detected significantly more patients with dysplasia than HD-WLE (18.8% vs 9.4%), OR 1.94 (95% CI 1.21–3.11, I 2 = 28%, P = 0.006, high CoE). This remained significant after excluding 2 RCT published as abstracts. A sensitivity analysis excluding a noninferiority RCT with a single experienced operator eliminated the results' heterogeneity, OR 2.46 (95% CI 1.56–3.90, I 2 = 0%). Although high-grade dysplasia detection was numerically higher in the DCE group (2.8% vs 1.1%), the difference was statistically insignificant, OR 2.21 (95% CI 0.64–7.62, I 2 = 0%, low CoE). DISCUSSION: Our updated meta-analysis supports DCE as a superior strategy in overall dysplasia detection in IBD, even with HD scopes. When expertise is available, DCE should be considered for surveillance colonoscopy in patients with high-risk IBD, with the acknowledgment that virtual chromoendoscopy shows equivalence in recent studies. Further multicenter trials with multiple endoscopists with varying expertise levels and longer-term outcome data showing a reduction in cancer or cancer-related death are needed.

16 September 2022 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
MKMihir Khunte
Mihir Khunte
NDNhu Dang
Nhu Dang
AZAnthony Zhong
Anthony Zhong
SKSoryan Kumar
Soryan Kumar
KKKendra Kamp
Kendra Kamp
SSSamir A. Shah
Samir A. Shah
INTRODUCTION: We evaluated trends in Medicare reimbursement for common gastrointestinal (GI) services from 2007 to 2022. METHODS: Top GI procedures and office/inpatient visits were identified. The Physician Fee Schedule Look-Up Tool from Centers for Medicare & Medicaid Services was queried to extract reimbursement data. Reimbursement trends were analyzed, accounting for inflation. RESULTS: GI procedures exhibited an average decrease in unadjusted and adjusted reimbursement of 7.0% and 33.0%, respectively. Reimbursement for patient visits exhibited an inflation-adjusted decrease of 4.9%. DISCUSSION: The analysis revealed a steady decline in adjusted reimbursement for both GI procedures and patient visits in the past 15 years.

1 March 2015 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
AKAnita Krishnarao
Anita Krishnarao
LLLauren de Leon
Lauren de Leon
RBRenee Bright
Renee Bright
HMHeather Moniz
Heather Moniz
MLMeaghan Law
Meaghan Law
SSSamir A. Shah
Samir A. Shah
Background. The incidence of Clostridium difficile infection (CDI) in inflammatory bowel disease (IBD) is increasing, and CDI has a negative impact on IBD outco

1 January 2019 in Journal of Hospital Medicine
Verified
Journal Article
Open access
PDF file
SSSamir A Shah
Samir A Shah
*Corresponding Author: Dr. Samir S. Shah, E-mail: Samir.Shah@cchmc.org; Telephone: 513-636-6222; Twitter: @SamirShahMD

12 August 2014 in Current Gastroenterology Reports
Verified
Journal Article
Closed access
PDF file
SSSamir A. Shah
Samir A. Shah
DRDavid T. Rubin
David T. Rubin
FFFrancis A. Farraye
Francis A. Farraye

1 June 2022 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
GRGiovanni A. Roldan
Giovanni A. Roldan
SJSehrish Jamot
Sehrish Jamot
KKKrzysztof Kopec
Krzysztof Kopec
ACAmber Charoen
Amber Charoen
DLDaniel Leffler
Daniel Leffler
SSSamir A. Shah
Samir A. Shah